Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ARUK 2021

23–26 March 2021 | Virtual Meeting

ARUK 2021

23–26 March 2021 | Virtual Meeting
The potential druggability of OAS1 leading to new AD and COVID-19 treatments 1:05
The potential druggability of OAS1 leading to new AD and COVID-19 treatments
Dervis Salih • 25 Mar 2021
Identifying innate immune system genes linked to AD 2:58
Identifying innate immune system genes linked to AD
Dervis Salih • 25 Mar 2021
The study of retinal vasculopathy to predict, detect and monitor Alzheimer’s disease 4:04
The study of retinal vasculopathy to predict, detect and monitor Alzheimer’s disease
Maya Koronyo-Hamaoui • 31 Mar 2021
The challenges of Alzheimer’s disease animal models and the use of human stem cells 2:04
The challenges of Alzheimer’s disease animal models and the use of human stem cells
Bryan Ng • 24 Mar 2021
Antibodies as research tools to study dementia 1:20
Antibodies as research tools to study dementia
Francesco Antonio Aprile • 31 Mar 2021
The impact of using human stem cells in dementia research 3:17
The impact of using human stem cells in dementia research
Bryan Ng • 24 Mar 2021
Investigating microstructural properties of SWM in Alzheimer’s disease 4:24
Investigating microstructural properties of SWM in Alzheimer’s disease
Tom Veale • 25 Mar 2021
The OAS1 gene increases risk of AD and COVID-19 2:48
The OAS1 gene increases risk of AD and COVID-19
Dervis Salih • 25 Mar 2021
Retinal imaging techniques and their applications on Alzheimer’s disease research 4:06
Retinal imaging techniques and their applications on Alzheimer’s disease research
Maya Koronyo-Hamaoui • 31 Mar 2021
The effect of tau protein knockout on stem cells of healthy individuals 4:50
The effect of tau protein knockout on stem cells of healthy individuals
Bryan Ng • 24 Mar 2021
The development of oligomer-specific antibodies and their potential use as a diagnostic tool 3:22
The development of oligomer-specific antibodies and their potential use as a diagnostic tool
Francesco Antonio Aprile • 31 Mar 2021
Future perspectives on the use of human stem cells to model Alzheimer’s disease 1:53
Future perspectives on the use of human stem cells to model Alzheimer’s disease
Bryan Ng • 24 Mar 2021
iPSC models of neurodegenerative disease 3:27
iPSC models of neurodegenerative disease
Selina Wray • 29 Mar 2021
Identifying a new link between TREM2 and IL-4 signaling in microglia 1:31
Identifying a new link between TREM2 and IL-4 signaling in microglia
Dervis Salih • 25 Mar 2021
Future perspectives on the study of retina in Alzheimer’s disease 3:50
Future perspectives on the study of retina in Alzheimer’s disease
Maya Koronyo-Hamaoui • 31 Mar 2021
Microglia associated with longevity and a lower AD risk 1:18
Microglia associated with longevity and a lower AD risk
Dervis Salih • 25 Mar 2021
The content of VJDementia is intended for healthcare professionals